Case Presentations in Medical Glaucoma: A Review of Therapeutic Advances

CONTENT SOURCE
This continuing medical education (CME)/continuing education (CE) activity captures content from a roundtable discussion that occurred on October 17, 2018.

ACTIVITY DESCRIPTION
Glaucoma is a leading cause of preventable blindness in the United States, and at least 3 million Americans have a form of this chronic disease. Somewhat asymptomatic, patients may lose more than 40% of their optic nerve fibers before noticing a loss of peripheral vision and seeking medical intervention. Given the rapid increase in the aging American population, as well as increases in groups at high risk for glaucoma (most of which have an age component), the burden of disease related to this condition becomes more significant each year.

TARGET AUDIENCE
This certified CME/CE activity is designed for optometrists managing glaucoma patients, glaucoma specialists, and general ophthalmologists involved in the management of glaucomatous disorders.